Hbk Investments L P Regeneron Pharmaceuticals, Inc. Transaction History

Hbk Investments L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $1.26 Million - $1.72 Million	-4,579 Reduced 26.24%	12,870 $4.83 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $7.2 Million - $8.51 Million	-19,351 Reduced 52.58%	17,449 $7.17 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $12 Million - $15.7 Million	33,357 Added 968.84%	36,800 $13.8 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $1.49 Million - $1.74 Million	3,443	3,443 $1.54 Million

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.